BridgeMD
New treatment option for Hopeless Tooth
Official title Performance of Next-X in Alveolar Ridge Preservation
ClinicalTrials.gov ID: NCT06698276
What this study is testing
- What it's testing
- The goal of this case series study is to evaluate the clinical and histological outcomes of a protocol for managing hopeless teeth, focusing on alveolar preservation and subsequent dental implant placement. The study will also assess the long-term success of prosthetic reconstruction.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults between 18 and 80 years of age.
- Requirement for single-rooted tooth extraction due to reasons such as caries, fractures, restorative issues, endodontic complications (e.g., root...
- Presence of at least one neighboring tooth adjacent to the extraction site.
- Maintaining adequate oral hygiene, indicated by bleeding on probing \<20% and plaque index \<20%.
- Presence of at least 50% of the buccal bone plate.
You likely can't join if
- All smokers, including smoking alternatives.
- Heavy drinker (\> 60 g of alcohol per day as a mean).
- Uncontrolled metabolic disorders e.g., diabetes mellitus, osteomalacia, thyroid disorder, severe renal or hepatic disorder.
- Prolonged corticosteroid therapy.
- Immunological impairment diseases.
- History of malignancy, radiotherapy, or chemotherapy for malignancy within the past five years.
See the full eligibility criteria
- Adults between 18 and 80 years of age.
- Requirement for single-rooted tooth extraction due to reasons such as caries, fractures, restorative issues, endodontic complications (e.g., root fracture, instrument fracture), orthodontic needs, or prosthetic...
- Presence of at least one neighboring tooth adjacent to the extraction site.
- Maintaining adequate oral hygiene, indicated by bleeding on probing \<20% and plaque index \<20%.
- Presence of at least 50% of the buccal bone plate.
- Classification of patients as ASA I or II status according to the American Society of Anesthesiologists Classification.
- All smokers, including smoking alternatives.
- Heavy drinker (\> 60 g of alcohol per day as a mean).
- Uncontrolled metabolic disorders e.g., diabetes mellitus, osteomalacia, thyroid disorder, severe renal or hepatic disorder.
- Prolonged corticosteroid therapy.
- Immunological impairment diseases.
- History of malignancy, radiotherapy, or chemotherapy for malignancy within the past five years.
- General contraindications for dental and/or surgical treatment (including patients who take anticoagulants or antiresorptives).
- Disease or condition affecting bone metabolism.
- Women of child-bearing age, not using a highly effective method of birth control.
- Pregnancy or breast feeding.
- Previous and concurrent medication affecting sinus healing in general (e.g., topical steroids, large doses of anti-inflammatory drugs).
- Acute or chronic oral infection or uncontrolled periodontal disease.
- Crestal bone defects at the implantation site, which require additional bone augmentation around the neck of the implant.
- Allergy to collagen.
- Participation in an investigational device or drug clinical trial within the last six month.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.